Jenburkt Pharmaceuticals

Stock Price vs Company Growth
1d
0.5%
1w
4.6%
1m
2.6%
3m
7.9%
6m
8.3%
1y
42.2%
5y
26.8%
10y
12.8%
all
21.8%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec16Dec18Jun20Dec21Jun23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

1,038 0.5%
937
1,174
Company Overview

Sales
149 Cr
Growth: 7.7%
Profit after Tax
31.4 Cr
Growth: 3.6%
Small Cap
458 Cr
P/E: 14.6x
Industry P/E: 30.9x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 149
Growth 7.7%
EBITDA 26.3%
P/S 3.1x
Dividend 1.8%
P/E 14.6x
Book Value ₹ 459
PEG Ratio 1.9x
ROE 16.4%
P/B 2.3x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Sep22Dec22Mar23Jun23Jun24
Promoters
Created with Highcharts 8.2.2Sep22Dec22Mar23Jun23Jun24
Others
Created with Highcharts 8.2.2Sep22Dec22Mar23Jun23Jun24
Increase    Decrease    No change
Company Profile Detailed

Jenburkt Pharmaceuticals Ltd, a venture to diversify into the healthcare and pharmaceutical industry, was formed in 1985 by the Bhuta family; late Hemendra N. Bhuta was the promoter of the company while the Bhuta Group was founded by Nandlal Mulji BhutaJenburkt is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange.
Investors (12)
Followers (1)